MediFind

Find a Doctor

Robert L. Ferris

University Of Pittsburgh Physicians
Radiology, Otolaryngology
Male
Practicing approx. 25 years

Bio


Robert Ferris is a Radiologist and an Otolaryngologist in Pittsburgh, Pennsylvania. He has been an author on 387 peer reviewed articles and participated in 5 clinical trials in the past 15 years. Dr. Ferris's top three areas of expertise are Head and Neck Squamous Cell Carcinoma, Squamous Cell Skin Carcinoma, and Tongue Cancer. He is licensed to treat patients in PA.

Contact

200 Lothrop St
Pittsburgh, PA 15213, US

Latest Research


Latest Advance
Study
  • Condition: Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Durvalumab with or without Tremelimumab
  • Number of Patients: 496
  • Published —
This study compared the clinical outcome of using durvalumab with or without tremelimumab to treat patients with recurrent or metastatic head and neck squamous cell carcinoma.
Latest Advance
Study
  • Condition: Cancer
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Immunotherapy
  • Number of Patients: 0
  • Published —
This article discusses immunotherapy in the treatment of various cancers.
Latest Advance
Study
  • Condition: Head and Neck Cancer
  • Journal: Oral oncology
  • Treatment Used: Immunotherapy
  • Number of Patients: 0
  • Published —
This article discusses advances in immunotherapy, new combinations of checkpoint inhibitors, and therapeutic vaccine treatment for head and neck cancer.
Latest Advance
Study
  • Condition: Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
  • Journal: Oral oncology
  • Treatment Used: Nivolumab
  • Number of Patients: 351
  • Published —
This study tested the safety and efficacy of using nivolumab to treat patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Latest Advance
Study
  • Condition: Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
  • Journal: Cancer
  • Treatment Used: Nivolumab
  • Number of Patients: 240
  • Published —
This study evaluated nivolumab in recurrent/metastatic squamous cell carcinoma of the head and neck after platinum therapy.
Latest Advance
Study
  • Condition: Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SSCHN)
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Nivolumab
  • Number of Patients: 0
  • Published —
This study assessed outcomes with nivolumab, by prior cetuximab exposure, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) who had experienced progression within 6 months of platinum-containing chemotherapy.
Latest Advance
Study
  • Condition: Head and Neck Squamous Cell Carcinomas (HNSCCs)
  • Journal: Nature reviews. Clinical oncology
  • Treatment Used: Combination of Radiotherapy and Chemotherapy
  • Number of Patients: 0
  • Published —
This review discusses the changing therapeutic landscape of head and neck squamous cell carcinomas (HNSCCs) that can arise in the oral cavity, oropharynx, hypopharynx and larynx.
Latest Advance
Study
  • Condition: Hypopharyngeal cancer treatment
  • Journal: Head & neck
  • Treatment Used: Surgery followed by add-on treatment
  • Number of Patients: 137
  • Published —
The study researched the outcomes of surgery followed by additional treatment in patients with hypopharyngeal cancer treatment.
Latest Advance
Study
  • Condition: Human Papillomavirus-Associated (HPV+) Oropharyngeal Squamous Cell Carcinoma (OPSCC)
  • Journal: Oral oncology
  • Treatment Used: Surgery with Adjuvant Radiation or Chemoradiation
  • Number of Patients: 1677
  • Published —
This study compared the clinical outcome of using surgery with adjuvant radiation or chemoradiation to treat patients with HPV+-associated OPSCC.
Latest Advance
Study
  • Condition: Recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN)
  • Journal: The oncologist
  • Treatment Used: Nivolumab
  • Number of Patients: 0
  • Published —
This study evaluated the overall survival (OS) benefits of Nivolumab compared to investigator's choice (IC) of chemotherapy as a first-line treatment approach for patients with Recurrent/metastatic head and neck cancer.

All Publications
View All


Publication
Study
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Published —
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies.

Contact

200 Lothrop St
Pittsburgh, PA 15213, US

Affiliations

  • Upmc Presbyterian Shadyside

Credentials

  • Graduate InstitutionKansas City College Of Medicine And Surgery
    1995
  • Licenses
    Specialist in PA
  • Board Certifications
    Otolaryngology

Insurance

Contact them to find out if they accept your insurance plan.